President Donald Trump promised in his plan for his first 100 days to cut red tape at the Food and Drug Administration and speed up the approval of life-saving drugs. The CEO of a Virginia-based pharmaceutical company spoke to One America’s Neil W. McCabe about how the FDA is different now from under the previous administration.
Visit us at:
Website: https://www.oann.com
Facebook: https://www.facebook.com/OneAmericaNewsNetwork
Twitter: https://twitter.com/OANN